Inventor
ROSATI ROBERT L
US32 patents
Patents
32 patentsUS5552412ASep 3, 1996
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
PFIZER194 citations99
US6441193B1Aug 27, 2002
Estrogen agonists/antagonists
PFIZER28 citations96
US6204286B1Mar 20, 2001
Estrogen agonists/antagonists
PFIZER62 citations96
US6153622ANov 28, 2000
Estrogen agonists/antagonists
PFIZER59 citations96
US6821989B2Nov 23, 2004
Method of treating certain cancers using an estrogen agonist/antagonist
PFIZER41 citations92
US6649657B2Nov 18, 2003
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER16 citations92
US6498172B1Dec 24, 2002
Prostaglandin agonists and their use to treat bone disorders
PFIZER25 citations92
US6288120B1Sep 11, 2001
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER30 citations92
US6124314ASep 26, 2000
Osteoporosis compounds
PFIZER42 citations92
US5703108ADec 30, 1997
Bone deposition by certain prostaglandin agonists
PFIZER35 citations92
US5442044AAug 15, 1995
Orally active renin inhibitors
PFIZER39 citations92
US5034376AJul 23, 1991
Nor-statine and nor-cyclostatine polypeptides
PFIZER25 citations92
US4814342AMar 21, 1989
Nor-statine and nor-cyclostatine polypeptides
PFIZER25 citations92
US6632834B2Oct 14, 2003
Compositions and methods for treating conditions responsive to estrogen
PFIZER42 citations91
USRE39558EApr 10, 2007
5-Substituted-6-cyclic-5,6,7,8-tetrahydronaphthalen 2-ol compounds which are useful for treating osteoporosis
PFIZER10 citations84
US7238721B2Jul 3, 2007
Pyrazole compounds for treatment of neurodegenerative disorders
PFIZER13 citations83
US6376502B1Apr 23, 2002
Osteoporosis compounds
PFIZER6 citations74
US4935405AJun 19, 1990
Nor-statine and nor-cyclostatine polypeptides
PFIZER15 citations74
US4923864AMay 8, 1990
Certain heterocyclic-hexanamides useful for treating hypertension
PFIZER9 citations74
US4348264ASep 7, 1982
Photocatalyzed process for producing carbapenams and carbapen-2-ems
PFIZER6 citations74
US6492412B2Dec 10, 2002
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER9 citations73
US6426359B1Jul 30, 2002
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
PFIZER12 citations73
US4729985AMar 8, 1988
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
PFIZER11 citations73
US7521464B2Apr 21, 2009
Pyrazole compounds for treatment of neurodegenerative disorders
PFIZER7 citations72
US6756388B1Jun 29, 2004
Benzothiophenes and related compounds as estrogen agonists
PFIZER11 citations71
US4749687AJun 7, 1988
Renin inhibitors containing statine or derivatives thereof
PFIZER13 citations68
US7442702B2Oct 28, 2008
Prostaglandin agonists
PFIZER2 citations63
US4859654AAug 22, 1989
Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
PFIZER2 citations63
US4429128AJan 31, 1984
Carbapenams and carbapen-2-ems and process therefor
PFIZER5 citations63
US6998423B2Feb 14, 2006
Prevention of loss and restoration of bone mass by certain prostaglandin agonists
PFIZER2 citations62
US4948913AAug 14, 1990
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
PFIZER2 citations62
US4992562AFeb 12, 1991
Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues
PFIZER1 citations52